FRANCES BURNS: Open Payments
NPI 1083688766 · LANOKA HARBOR, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,756 in 124 payments from 18 companies in 2025. Trend: 2023 $2,014 · 2024 $3,010 · 2025 $2,756
Food & beverage: $2,756
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 14 | $414 |
| Axsome Therapeutics, Inc. | 12 | $392 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $326 |
| Vanda Pharmaceuticals Inc. | 8 | $309 |
| ABBVIE INC. | 22 | $307 |
| Otsuka America Pharmaceutical, Inc. | 18 | $252 |
| Lundbeck LLC | 11 | $197 |
| E.R. Squibb & Sons, L.L.C. | 3 | $152 |
| Neurocrine BioSciences, Inc. | 6 | $105 |
| Bausch Health US, LLC | 5 | $86 |
Products named: REXULTI, Auvelity, CAPLYTA, FANAPT, VRAYLAR, INVEGA SUSTENNA, SPRAVATO, COBENFY.
Industry payments across NJ — which companies pay providers there.
